August 2010

Bayer Schering Pharma AG, Berlin, Germany, announced that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application to the US for gadobutrol injection, a gadolinium-based contrast agent for magnetic resonance imaging (MRI).

[adsense:336x280:8701650588]

In patients with mild Alzheimer's disease (AD), deep brain stimulation (DBS) modulates specific brain circuits important in memory and is safe, according to results of the first phase 1 study of DBS for AD, published online July 30 in the Annals of Neurology.

People infected with Hepatitis B virus are around twice as likely to develop non-Hodgkin Lymphoma, according to a study published in Lancet Oncology. Hepatitis B was already known to cause liver cancer, and some scientists had suspected it might cause lymphoma.

Merck said that its hepatitis C drug boceprevir hit its primary endpoints in two Phase III studies and will file for an approval of the potential blockbuster by the end of this year. And analysts quickly began to handicap Merck's chances against Vertex, which has compiled a mountain of positive data for its hep C drug telaprevir.

[adsense:336x280:8701650588]

Sri Baba Mast Nath Math is the most ancient and the most visited place of the Nath Sect, belonging to Kanphada Yogis. This is the premier Tapasthali of math yogis and is distanced 7 kilometers away from Rohtak city and 1 kilometer away from Maharishi Dayanand University campus on Delhi Rohtak National Highway No. 10. The Math has been embedded ancient civilization and is constantly rendering service for the betterment of the Human race.

[adsense:336x280:8701650588]

Apex is a people based organization and its strengths flow from its people. Apex is among the ‘top 50 fastest growing Indian pharma companies’, with most of its products enjoying leadership position in their segments. The company has ambitious plans to expand its product portfolio and expand its reach in the international market.

Indegene's scientific and competitive intelligence services lend actionable insights to clients to support their strategic decision making. We provide scientific, clinical, and competitive insights to help align the business development, licensing, clinical development, and marketing activities of our clients to current and future market needs.

Shreya Life Sciences is the Indian arm of Moscow based Shreya Group which currently operates in India, Russia, CIS countries and Africa. Shreya is one of the market leaders in Antiplatelet segment, Gl care, Nutritionals, Antimalarials & Antibiotics, Insulin, Cardiology & Diabetology markets.